CellaVision AB (publ) (CEVI) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome, everyone, and thank you for joining us today. My name is Steve Ferguson. Welcome to Celevision Q2 Report 2026. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to CEO Steve Ferguson. Please go ahead. Good morning, everyone, and thank you for joining us today. My name is Steve Ferguson, and with me is our Chief Financial Officer, Monika Jonsson. We appreciate you taking the time to join us this morning as we present CELAVision's results for the second quarter of 2026. Following the presentation, both Monika and I will be happy to take questions. As this is my first quarterly earnings call since joining CELAVision as CEO on June the 5th, I'd also like to take a moment just to very briefly introduce myself. Before joining Cellavision, I spent more than 25 years in international leadership roles across the life science, diagnostic and healthcare industries. Most recently, I was serving as CEO of Medics Biochemica in Finland, following senior commercial and operational leadership positions at Thermo Fisher Scientific, or Fadia, in Uppsala, and prior to that with Lundbeck, based in Saalbu in Copenhagen. I'm really super excited to be part of Cellavision. and to the challenge ahead, and I look forward to working together with our very talented team, our partners, and all of you as we continue to build on the company's strong foundation to advance laboratory workflow and diagnostic certainty through intelligent microscopy. I'm speaking to you this morning from Vancouver, where it's 2 a.m., so I'll do my best to keep our energy high during this call. So with that,...